about
A scoping review of weight bias by community pharmacists towards people with obesity and mental illnessDeprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping reviewCommunity pharmacists' experiences in mental illness and addictions care: a qualitative study.Partnering to enhance mental health care capacity in communities: A qualitative study of the More Than Meds programCanadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorderDrug information resources used by nurse practitioners and collaborating physicians at the point of care in Nova Scotia, Canada: a survey and review of the literatureFrom personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmaciesAdministrative claims data analysis of nurse practitioner prescribing for older adults.Prescribing trends of antipsychotics in youth receiving income assistance: results from a retrospective population database studyCommunity pharmacists and the assessment and management of suicide risk.Public perceptions of pharmacist expanded scope of practice services in Nova Scotia.Pharmacist work stress and learning from quality related events.System struggles and substitutes: A qualitative study of general practitioner and psychiatrist experiences of prescribing antipsychotics to children and adolescentsPharmacy students' experiences in provision of community pharmacy mental health services.Discharge instructions for caregivers in the context of pediatric emergency care: a narrative synthesis protocol.Essential Content for Discharge Instructions in Pediatric Emergency Care: A Delphi Study.Development and feasibility testing of the Pediatric Emergency Discharge Interaction Coding Scheme.Cost-effectiveness of a nurse practitioner-family physician model of care in a nursing home: controlled before and after study.Bridging the gap: knowledge seeking and sharing in a virtual community of emergency practice.A theory-informed approach to mental health care capacity building for pharmacists.International consensus study of antipsychotic dosing.A scoping review of community pharmacists and patients at risk of suicide.Community pharmacists' attitudes on suicide: A preliminary analysis with implications for medical assistance in dying.Pharmacists' participation in an inhaled respiratory medication program: reimbursement of professional fees.Pharmacists' performance in a telephone-based simulated patient study after a mental health capacity-building program.An opportunity for pharmacists and physicians to collaborate to prevent violence.Patient care activities by community pharmacists in a capitation funding model mental health and addictions program.Website Analytics of a Google Ads Campaign for a Men's Mental Health Website: Comparative AnalysisA survey of Canadian and Australian pharmacists' stigma of suicideCommunity pharmacists' experiences and people at risk of suicide in Canada and Australia: a thematic analysisThe patient experience in a community pharmacy mental illness and addictions program
P50
Q26740321-632DB5B0-7ED3-4B96-A08A-6BBBA2073D84Q26826838-A3E7614F-2CF3-4DAE-B976-9AB9ADE6060DQ27302130-85C13858-575F-423F-90FB-514E0EB6505DQ27323732-D0246589-910E-4012-AF57-4A03DE60A164Q28260681-7DB48A5E-74CC-4641-85E6-01C0BA93D198Q30478044-49994E01-D002-42CF-ACC4-EF7A0FBAA71EQ30821217-01ACD357-45F1-4D71-8B33-BE796FCC2AEEQ33492980-1682A802-8156-483D-91D2-CC9070BE8BEDQ34868848-C650F12D-9C78-492E-B2B4-70F80E944148Q35932652-6FFAB2B6-8079-4144-8BAB-23AE61BC6F60Q36032367-94C763D7-DB4D-4802-B74A-134927949117Q37253294-BD7CF9A8-9976-4DED-8457-A4A3FAB437C8Q37391342-9B2CF777-7EC9-4944-8684-F2A6838F8A4CQ37537111-FE1D582B-1E62-4274-A989-B38A136E708AQ38894454-6F34CEB1-7D91-48F7-9546-7BB20DD4908BQ39024609-B203A8E0-F27D-4685-B93A-1D90BABC0F0BQ39081707-2D3A1751-402E-493E-B97A-7AFCECD49BE4Q39817965-6124732D-DECE-45FA-91CB-B246C805FF1BQ39897717-B440D7AB-6568-4192-BA5C-BE5A9E3C6E07Q41953940-CD446479-73A4-4825-97C3-75C3F7CD5CAEQ43111655-8150E750-0959-47F4-867E-5C31613EA583Q45844561-374F8818-39E4-4F92-83BD-53DBA59FDA99Q47659898-BAA9E81D-ECA3-468F-9BA1-2CD5C7863B3AQ47844683-189D25FC-D753-4253-B7E3-3DA7F0560E7DQ47952497-CBD52731-1268-4627-8FBA-00688BEC2EBCQ53729339-51C0FD3F-CD34-4C29-AFE3-5B64475A1909Q55399229-2A11C206-766E-4609-9493-18D2B6A840F5Q60957036-519BB4A2-905B-4CD0-BCA1-CB78D0B0E4FEQ61818428-0673E16F-F8E0-49FA-9F71-B98ED62BACAFQ89220193-DEA09483-2164-4B74-9E5B-BA707329E63AQ92479627-89FC0B5D-9685-48DA-97D9-32AAD9C7F46A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrea L Murphy
@ast
Andrea L Murphy
@en
Andrea L Murphy
@es
Andrea L Murphy
@nl
type
label
Andrea L Murphy
@ast
Andrea L Murphy
@en
Andrea L Murphy
@es
Andrea L Murphy
@nl
altLabel
Andrea Murphy
@en
prefLabel
Andrea L Murphy
@ast
Andrea L Murphy
@en
Andrea L Murphy
@es
Andrea L Murphy
@nl
P106
P1153
8248032600
P31
P496
0000-0001-5093-6681